Gainers

• Ensysce Biosciences (NASDAQ:ENSC) shares rose 40.4% to $0.55 during Friday's pre-market session. The market value of their outstanding shares is at $1.3 million.
• Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock rose 23.18% to $6.43. The market value of their outstanding shares is at $9.5 million.
• Neurogene (NASDAQ:NGNE) shares rose 20.93% to $23.8. The company's market cap stands at $304.8 million.
• Caris Life Sciences (NASDAQ:CAI) stock increased by 14.81% to $22.09. The market value of their outstanding shares is at $5.4 billion. As per the press release, Q4 earnings came out yesterday.
• BioAtla (NASDAQ:BCAB) shares moved upwards by 10.78% to $0.26. The market value of their outstanding shares is at $17.6 million.
• Candel Therapeutics (NASDAQ:CADL) stock increased by 8.73% to $5.6. The company's market cap stands at $282.7 million.

Losers

• Emergent BioSolutions (NYSE:EBS) stock decreased by 21.8% to $8.68 during Friday's pre-market session. The company's market cap stands at $582.9 million. As per the news, the Q4 earnings report came out yesterday.
• XORTX Therapeutics (NASDAQ:XRTX) shares fell 17.58% to $0.33. The market value of their outstanding shares is at $2.8 million.
• Ginkgo Bioworks Holdings (NYSE:DNA) stock declined by 16.69% to $8.09. The market value of their outstanding shares is at $588.3 million. As per the press release, Q4 earnings came out yesterday.
• Fortrea Holdings (NASDAQ:FTRE) shares declined by 13.43% to $9.35. The market value of their outstanding shares is at $997.9 million. As per the news, the Q4 earnings report came out yesterday.
• Amphastar Pharma (NASDAQ:AMPH) shares fell 13.18% to $23.0. The company's market cap stands at $1.2 billion. The company's, Q4 earnings came out yesterday.
• Seer (NASDAQ:SEER) stock declined by 12.99% to $1.81. The company's market cap stands at $117.0 million. As per the press release, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.